Tom 12, Nr 1 (2017)
Medycyna oparta na faktach – co nowego?
Opublikowany online: 2017-03-03
Wyświetlenia strony
664
Wyświetlenia/pobrania artykułu
922
Najnowsze doniesienia kardiologiczne z kolebki światowego jazzu — relacja z AHA Scientific Sessions 2016 w Nowym Orleanie
DOI: 10.5603/FC.2017.0017
Folia Cardiologica 2017;12(1):118-123.
Streszczenie
Brak
Referencje
- Hiatt WR, Fowkes FG, Heizer G, et al. EUCLID Trial Steering Committee and Investigators. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Engl J Med. 2017; 376(1): 32–40.
- Nissen SE, Yeomans ND, Solomon DH, et al. PRECISION Trial Investigators. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016; 375(26): 2519–2529.
- Taggart DP, Altman DG, Gray AM, et al. ART Investigators. Randomized trial of bilateral versus single internal-thoracic-artery grafts. N Engl J Med. 2016; 375(26): 2540–2549.
- Gibson CM, Pinto DS, Chi G, et al. Recurrent hospitalization among patients with atrial fibrillation undergoing intracoronary stenting treated with 2 treatment strategies of rivaroxaban or a dose-adjusted oral vitamin K antagonist treatment strategy. Circulation. 2017; 135(4): 323–333.
- Gibson CM, Mehran R, Bode C, et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med. 2016; 375(25): 2423–2434.
- Lewis GD, McNulty S, Hernandez AF, et al. Oral iron repletion effects on oxygen uptake in heart failure (IRONOUT HF). American Heart Association 2016 Scientific Sessions. November 16, 2016. New Orleans.
- Van Veldhuisen DJ, Ponikowski P, Metra M, et al. Effect of ferric carboxymaltose on exercise capacity in patients with iron deficiency and chronic heart failure (EFFECT-HF): A randomized controlled study. American Heart Association 2016 Scientific Sessions. November 16, 2016. New Orleans.
- Ray KK, Landmesser U, Leiter LA, et al. Insights from new therapeutic trials for lipids. ORION-1. Inclisiran inhibits PCSK9 synthesis by RNA interference. Planned interim analysis of a multi-center randomized controlled dose-finding trial. American Heart Association's Scientific Sessions 2016. November 12–16, 2016. New Orleans.
